Kerendia

Medicinal product

(Invented) name

Kerendia

Active substance (s)

Finerenonas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA05, finerenone

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2022-02-16

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Finerenonas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108171	94275	1094275	lizdinė plokštelė	N14		Receptinis	EU/1/21/1616/006	Netiekiama	-	-	No	-	-
108172	94276	1094276	lizdinė plokštelė	N28		Receptinis	EU/1/21/1616/007	Tiekiama	2025-01-28	-	No	-	-
108173	94277	1094277	lizdinė plokštelė	N98		Receptinis	EU/1/21/1616/008	Netiekiama	-	-	No	-	-
108174	94278	1094278	dalomoji lizdinė plokštelė	N100×1		Receptinis	EU/1/21/1616/009	Netiekiama	-	-	No	-	-
108175	94279	1094279	buteliukas	N100		Receptinis	EU/1/21/1616/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-02-16	Registruotas